文献速递肺外科

肺癌肺叶切除术后体重下降与预后的关联分析

Analysis of postoperative weight loss associated with prognosis after lobectomy for lung cancer.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究回顾性分析2017年12月至2021年6月269例原发性肺癌根治性肺叶切除术患者,评估术后3、6、12个月体重较术前变化百分比。187例(69.5%)在术后1年内出现体重下降,最大体重下降四分位距为2.0-8.2%(中位数4.0%),严重体重下降定义为≥8%。术后6至12个月体重下降与较差的总生存和无复发生存相关(P<0.05)。

要点

  • 术后1年内69.5%(187/269)患者出现体重下降,最大下降中位数4.0%。
  • 术后6至12个月体重下降与较差总生存和无复发生存相关(P<0.05)。
  • 严重体重下降组总生存、无复发生存和非癌症特异性生存均更差(P=0.001、0.005、0.019)。

核心结论

  • 术后6至12个月体重下降和严重体重下降与不良预后相关;对具有预测因素的患者,持续营养管理对预防危及生命的体重下降很重要。

研究设计与样本

  • 回顾性分析2017年12月至2021年6月接受原发性肺癌根治性肺叶切除术患者的资料,共269例;根据术前体重计算术后3、6、12个月体重增减百分比,体重下降时间分为0-3、3-6、6-12个月,并评估严重体重下降(体重下降≥8%)与预后的关系。

主要发现

  • 269例中187例(69.5%)术后1年内出现体重下降,最大体重下降四分位距为2.0-8.2%(中位数4.0%)。
  • 25例(9.3%)死亡,其中9例死于原发性肺癌、16例死于非肺癌原因;45例(16.7%)发生癌症复发。
  • 术后6至12个月体重下降与较差的总生存和无复发生存相关(P<0.05,两者)。
  • 严重体重下降组的总生存、无复发生存和非癌症特异性生存更差(P=0.001、0.005和0.019)。
  • 体重指数<18.5 kg/m2和特发性肺纤维化是预测因素(P<0.05,所有);年龄≥70岁和严重术后并发症是严重体重下降的预测因素(P<0.05,所有)。

关键数值与推荐

  • 严重体重下降定义为体重下降≥8%。
  • 最大体重下降四分位距为2.0-8.2%(中位数4.0%)。
  • 体重指数<18.5 kg/m2和特发性肺纤维化为预测因素(P<0.05,所有)。
  • 年龄≥70岁和严重术后并发症为严重体重下降的预测因素(P<0.05,所有)。

临床怎么用

  • 原文结论指出,对具有预测因素的患者,持续营养管理对预防危及生命的体重下降很重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Weight assessment is an easy-to-understand method of health checkup. The present study investigated the association between weight loss (WL) after lung cancer (LC) surgery and short-mid-term prognosis. METHODS: The data of patients who underwent radical lobectomy for primary LC were assessed between December 2017 and June 2021. Percentage weight gain or loss was determined at 3, 6 and 12 months postoperatively based on preoperative weight. The timing of decreased weight was divided into 0-3, 3-6 and 6-12 months. We also evaluated the relationship between severe WL (SWL) and prognosis. RESULTS: We reviewed 269 patients, of whom 187 (69.5%) showed WL within 1 year after surgery. The interquartile range for maximal WL was 2.0-8.2% (median 4.0%). Furthermore, we defined SWL as WL ≥8%. Twenty-five patients (9.3%) died: 9 from primary LC and 16 from non-LC causes. Cancer recurrences occurred in 45 patients (16.7%). WL occurred from 6 to 12 months postoperatively was associated with poor overall survival and recurrence-free survival (P < 0.05, both). Body mass index <18.5 kg/m2 and idiopathic pulmonary fibrosis were predictive factors (P < 0.05, all). In the SWL group, overall survival, recurrence-free survival and non-cancer-specific were worse (P = 0.001, 0.005 and 0.019, respectively). Age ≥70 years and severe postoperative complications were predictive factors for SWL (P < 0.05, all). CONCLUSIONS: WL from 6 to 12 months postoperatively and SWL were associated with poor prognosis. Ongoing nutritional management is important to prevent life-threatening WL in patients with predictive factors.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Nakada T, Tsukamoto Y, Kato D, et al. Analysis of postoperative weight loss associated with prognosis after lobectomy for lung cancer. Eur J Cardiothorac Surg. 2022. PMID: 36173323. doi:10.1093/ejcts/ezac479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。